Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
4Customers
3Debt Items
1Related Chains
Source-Backed Evidence Depth
Milestone Pharmaceuticals Inc. (MIST) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
9Total relationships
2Distinct source URLs
8High confidence
0.873Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Milestone Pharmaceuticals Inc. Suppliers
Ticker
Name
Confidence
Evidence
RTW-INVESTMENTS-LP
RTW-INVESTMENTS-LP
92%
On March 27, 2023, the Company entered into a note purchase agreement, or the 'Note Purchase Agreement,' with RTW Investments LP and certain of its affiliates, or collectively, 'RTW.'
Milestone Pharmaceuticals Inc. Customers
Ticker
Name
Confidence
Evidence
CORXEL
CORXEL
92%
Under the License Agreement, the Company granted Corxel exclusive development and commercialization rights to any pharmaceutical product that uses a device to deliver etripamil by nasal spray
JI-XING-PHARMACEUTICALS-LIMITED
JI-XING-PHARMACEUTICALS-LIMITED
90%
our licensing partner, Corxel (formerly Ji Xing Pharmaceuticals Limited, JIXING)
RTW-INVESTMENTS-LP
RTW-INVESTMENTS-LP
90%
On May 15, 2021, the Company entered into a license and collaboration agreement, or the License Agreement, with Corxel, which is an entity affiliated with RTW Investments, LP, or “RTW,” an existing s…
INCARDA-THERAPEUTICS-INC
INCARDA-THERAPEUTICS-INC
62%
lar therapies. We believe an organization of this size could potentially allow us to reach prescribers that collectively care for most patients diagnosed with PSVT in the United States. Given the imp…
Milestone Pharmaceuticals Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
MIST-DEBT-10991
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2023-12-31.
MIST-DEBT-10990
Warrants outstanding: 0.01
90%
xbrl warrant detail from xbrl 2022-12-31.
MIST-DEBT
Debt stack $59.2M
90%
Market cache reports total debt of $59.2M.
Milestone Pharmaceuticals Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Milestone Pharmaceuticals Inc..
Milestone Pharmaceuticals Inc. Ownership
Holder
Name
Confidence
Evidence
MIST-OWNER-RTW-INVESTMENTS-LP
RTW INVESTMENTS, LP
90%
13F overlay lists RTW INVESTMENTS, LP as top holder; 86 tracked holders.
Milestone Pharmaceuticals Inc. Extended Supply Chain Network
